190 A.3d 419
N.J.2018Background
- Plaintiff Janell Brugaletta was treated at Chilton Memorial Hospital (CMH) for a perforated appendix and later developed necrotizing fasciitis; she alleges resulting permanent injuries and missed antibiotic doses.
- Plaintiff served interrogatories seeking statements and related documents; CMH withheld two incident reports prepared under the Patient Safety Act (PSA), invoking the PSA self-critical-analysis privilege and other privileges.
- The trial court conducted an in camera review, concluded a Serious Preventable Adverse Event (SPAE) occurred, ordered a redacted report disclosed to plaintiff, and directed CMH to report the SPAE to the Department of Health (DOH).
- The Appellate Division reversed, holding the privilege attaches if the facility complied with PSA procedures and that the trial court’s SPAE finding lacked expert support.
- The Supreme Court: (1) held the PSA privilege covers materials developed exclusively in compliant self-critical analyses even if the event is later determined not to be a SPAE; (2) ruled a trial court should not substitute itself for DOH/administrative review of PSA SPAE determinations; but (3) remanded because defendants had an outstanding discovery duty under Rule 4:17-4(d) to make the underlying, non-privileged factual information accessible.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Scope of PSA self-critical-analysis privilege | Privilege should not shelter factual underlying information or permit hospitals to withhold facts; courts must review SPAE findings to protect patient right to know | Privilege protects all documents developed exclusively during a compliant PSA self-critical analysis regardless of outcome; no judicial role to second-guess SPAE determinations | Privilege applies to documents developed exclusively in a compliant PSA process and is not abrogated by a courts disagreement about whether a SPAE occurred |
| Judicial review of SPAE determinations | Courts should be able to review SPAE findings to enforce patient notification and disclosure rights | PSA vests oversight and enforcement with DOH; courts should not act as administrative factfinders of SPAEs | Trial courts should not determine whether a SPAE occurred or replace DOH regulatory functions |
| Availability of underlying factual information | Brugaletta: hospital should bear burden to disclose or narrate factual data because plaintiffs lack access to privileged materials | CMH: underlying facts already produced in patient chart; privilege need not be pierced | Underlying non-privileged factual information remains discoverable; courts may order specifying guidance or a narrative to locate facts in voluminous records under Rule 4:17-4(d) |
| Proper discovery remedy when privilege asserted | Release of a redacted self-critical report or court-ordered disclosure of SPAE | Maintain privilege and point plaintiff to records already produced | Court may not order release of PSA self-critical documents (even redacted); but may require the responding party to provide a reasonably specific narrative or specification pointing to the non-privileged source records (per R.4:17-4(d)) |
Key Cases Cited
- C.A. ex rel. Applegrad v. Bentolila, 219 N.J. 449 (N.J. 2014) (interpreting PSA privilege and regulatory framework)
- Brugaletta v. Garcia, 448 N.J. Super. 404 (App. Div. 2017) (Appellate Division opinion reversing trial court discovery order)
- Christy v. Salem, 366 N.J. Super. 535 (App. Div. 2004) (balancing plaintiff discovery rights against peer-review/public-interest privileges)
- Capital Health Sys., Inc. v. Horizon Healthcare Servs., Inc., 230 N.J. 73 (N.J. 2017) (standard of review for discovery rulings)
- Al Barnett & Son, Inc. v. Outboard Marine Corp., 611 F.2d 32 (3d Cir. 1979) (federal guidance on when a responding party must supply a narrative vs. citing voluminous records)